These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38704364)

  • 1. Targeting senescent cells with NKG2D-CAR T cells.
    Deng Y; Kumar A; Xie K; Schaaf K; Scifo E; Morsy S; Li T; Ehninger A; Bano D; Ehninger D
    Cell Death Discov; 2024 May; 10(1):217. PubMed ID: 38704364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates.
    Yang D; Sun B; Li S; Wei W; Liu X; Cui X; Zhang X; Liu N; Yan L; Deng Y; Zhao X
    Sci Transl Med; 2023 Aug; 15(709):eadd1951. PubMed ID: 37585504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.
    Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ
    Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells.
    Yang D; Sun B; Dai H; Li W; Shi L; Zhang P; Li S; Zhao X
    J Immunother Cancer; 2019 Jul; 7(1):171. PubMed ID: 31288857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells.
    Han Y; Xie W; Song DG; Powell DJ
    J Hematol Oncol; 2018 Jul; 11(1):92. PubMed ID: 29980239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer.
    Zhang Y; Liang K; Zhou X; Zhang X; Xu H; Dai H; Song X; Yang X; Liu B; Shi T; Wei J
    Cancer Sci; 2023 Jul; 114(7):2798-2809. PubMed ID: 37151176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
    Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells.
    Sun B; Yang D; Dai H; Liu X; Jia R; Cui X; Li W; Cai C; Xu J; Zhao X
    Cancer Immunol Res; 2019 Nov; 7(11):1813-1823. PubMed ID: 31484657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.
    Murad JM; Baumeister SH; Werner L; Daley H; Trébéden-Negre H; Reder J; Sentman CL; Gilham D; Lehmann F; Snykers S; Sentman ML; Wade T; Schmucker A; Fanger MW; Dranoff G; Ritz J; Nikiforow S
    Cytotherapy; 2018 Jul; 20(7):952-963. PubMed ID: 30180944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
    Driouk L; Gicobi JK; Kamihara Y; Rutherford K; Dranoff G; Ritz J; Baumeister SHC
    Front Immunol; 2020; 11():580328. PubMed ID: 33384686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach for relapsed/refractory FLT3
    Li KX; Wu HY; Pan WY; Guo MQ; Qiu DZ; He YJ; Li YH; Yang DH; Huang YX
    Mol Cancer; 2022 Mar; 21(1):66. PubMed ID: 35246156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia
    Ibáñez-Navarro M; Fernández A; Escudero A; Esteso G; Campos-Silva C; Navarro-Aguadero MÁ; Leivas A; Caracuel BR; Rodríguez-Antolín C; Ortiz A; Navarro-Zapata A; Mestre-Durán C; Izquierdo M; Balaguer-Pérez M; Ferreras C; Martínez-López J; Valés-Gómez M; Pérez-Martínez A; Fernández L
    Front Immunol; 2023; 14():1187665. PubMed ID: 37928520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction.
    Amor C; Fernández-Maestre I; Chowdhury S; Ho YJ; Nadella S; Graham C; Carrasco SE; Nnuji-John E; Feucht J; Hinterleitner C; Barthet VJA; Boyer JA; Mezzadra R; Wereski MG; Tuveson DA; Levine RL; Jones LW; Sadelain M; Lowe SW
    Nat Aging; 2024 Mar; 4(3):336-349. PubMed ID: 38267706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion.
    He C; Zhou Y; Li Z; Farooq MA; Ajmal I; Zhang H; Zhang L; Tao L; Yao J; Du B; Liu M; Jiang W
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction.
    Amor C; Fernández-Maestre I; Chowdhury S; Ho YJ; Nadella S; Graham C; Carrasco SE; Nnuji-John E; Feucht J; Hinterleitner C; Barthet VJA; Boyer JA; Mezzadra R; Wereski MG; Tuveson DA; Levine RL; Jones LW; Sadelain M; Lowe SW
    Res Sq; 2023 Sep; ():. PubMed ID: 37841853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.
    Parihar R; Rivas C; Huynh M; Omer B; Lapteva N; Metelitsa LS; Gottschalk SM; Rooney CM
    Cancer Immunol Res; 2019 Mar; 7(3):363-375. PubMed ID: 30651290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senolytic CAR T cells reverse senescence-associated pathologies.
    Amor C; Feucht J; Leibold J; Ho YJ; Zhu C; Alonso-Curbelo D; Mansilla-Soto J; Boyer JA; Li X; Giavridis T; Kulick A; Houlihan S; Peerschke E; Friedman SL; Ponomarev V; Piersigilli A; Sadelain M; Lowe SW
    Nature; 2020 Jul; 583(7814):127-132. PubMed ID: 32555459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel MICA/B-targeted chimeric antigen receptor augments the cytotoxicity of NK cells against tumor cells.
    Guo C; Dong M; Wang X; Yu J; Jin X; Cheng S; Cui F; Qian Y; Bao Q; Zhi L; Niu Z; Li M; Zhu W
    Biochem Biophys Res Commun; 2024 May; 710():149918. PubMed ID: 38598902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
    Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
    EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.